Friday, January 31, 2020 11:31:22 AM
Right. I sit in the .03-.05 range. This is peanuts compared to where this is going. Betting to guess that this wont sit on the OTC for too long. With the right merger details I'm thinking this could be an overnight success for all involved.
Recent IRME News
- IR-MED Ltd. Announces Launch of First-in-Human Clinical Trial of Its DiaSafe(TM) Device for Diabetic Foot Ulcer (DFU) Assessment • Newsfile • 11/03/2025 09:30:00 PM
- IR-MED's Key Clinical and Media Milestones • Newsfile • 10/27/2025 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 08:08:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2025 08:06:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2025 08:21:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2025 08:05:51 PM
